Insider Holders & Insider Ownership - HALOZYME THERAPEUTICS INC. (HALO)

List of insiders holdings for HALOZYME THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
KIRK RANDAL J
10% Owner
2019-11-05 16:53:107,046,385
0
7,046,385Form 13D
Frost Gregory Ian
CEO, President
2013-12-11 19:33:003,676,911
0
3,676,911Form 4
LECHNER IRA M
Director
2004-03-19 14:12:33100,000
1,052,329
1,152,329Form 3
MERCALDO EDWARD L
Director
2004-03-19 14:13:19126,944
692,994
819,938Form 3
Wilson Mark S
Vice President
2005-02-11 15:46:01544,240
0
544,240Form 3/A
Rynard Carolyn
Vice President
2005-02-11 15:55:34494,240
0
494,240Form 3/A
RAMSAY DAVID A
VP and Chief Financial Officer
2015-02-06 19:52:31458,582
0
458,582Form 4
FALBERG KATHRYN E
Director
2016-05-06 16:47:56358,253
0
358,253Form 4
Engler Robert
Director
2014-08-18 16:59:47273,176
0
273,176Form 4
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
2024-03-26 19:38:51229,891
0
229,891Form 4
Leff Jonathan A
VP, Chief Medical Officer
2009-08-07 20:20:32200,000
0
200,000Form 4
MATSUI CONNIE
Director
2023-05-09 18:21:33198,375
0
198,375Form 4
Armour Alison A.
SVP, Research & Development
2019-06-04 16:44:05195,278
0
195,278Form 4
Torley Helen
PRESIDENT AND CEO
2024-02-27 17:01:21182,746
0
182,746Form 4
PATTON JOHN STUART
Director
2014-08-21 17:07:42179,876
0
179,876Form 4
Kelley Kenneth J
Director
2021-04-14 16:19:55179,833
0
179,833Form 4
Yocum Richard C
VP-Clinical Development
2008-02-08 17:50:38150,943
0
150,943Form 4
Stelzer Laurie
SVP, Chief Financial Officer
2020-02-24 20:03:57127,559
10000
137,559Form 4
Hooper Matthew
Vice Pres & General Counsel
2007-11-13 16:35:47125,000
0
125,000Form 4
Posard Matthew L.
Director
2023-05-09 18:27:10124,625
0
124,625Form 4
Lim Jonathan E
Chief Executive Officer
2010-02-08 17:06:43120,000
0
120,000Form 4
Countouriotis Athena
SVP and Chief Medical Officer
2017-02-24 16:06:20118,493
0
118,493Form 4
Gergen Mark J
SVP, Chief Operating Officer
2017-02-24 16:05:43118,493
0
118,493Form 4
GUSTAFSON KURT A
Vice President and CFO
2013-02-06 18:58:1299,200
0
99,200Form 4
Shaffer James P
VP & Chief Commercial Officer
2014-02-10 17:57:1281,500
0
81,500Form 4
LIU JEAN I
VP & General Counsel
2014-02-10 17:55:1481,500
0
81,500Form 4
BIZZARI JEAN-PIERRE
Director
2023-05-09 18:09:2478,186
0
78,186Form 4
Hickey Benjamin
SVP, Chief Commerical Officer
2019-10-01 19:10:1273,873
0
73,873Form 4
LEONHARDT HARRY J
SVP, GC
2019-04-15 16:08:0166,373
0
66,373Form 4
Henderson Jeffrey William
Director
2023-05-09 18:19:0258,481
0
58,481Form 4
Snyder Mark Howard
SVP, GENERAL COUNSEL
2024-02-27 17:08:3257,109
0
57,109Form 4
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
2024-02-27 17:05:3554,473
0
54,473Form 4
Connaughton Bernadette
Director
2023-05-09 18:12:0451,657
0
51,657Form 4
Thornton Steven T
Director
2008-05-09 18:26:1850,000
0
50,000Form 4
Sun Elaine D
SVP, Chief Financial Officer
2021-04-01 19:43:3344,618
0
44,618Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
2019-08-05 20:11:3938,584
0
38,584Form 4
LITTLE ROBERT J
VP, Chief Commercial Officer
2010-02-08 17:52:4128,000
0
28,000Form 4
Matsuda Masaru
SVP, General Counsel
2021-09-07 17:42:2426,932
0
26,932Form 4
Miyashita Akiko Moni
Director
2023-05-09 18:24:0425,642
0
25,642Form 4
DAY MELLISSA
former officer, director
Director
2004-03-12 13:24:0222,374
0
22,374Form 4
Duncan Barbara Gayle
Director
2023-05-09 18:16:2420,624
0
20,624Form 4
Daly James M
Director
2023-08-15 16:04:2820,503
0
20,503Form 4
Fallon William J
VP, Manufacturing & Operations
2011-05-11 19:44:0419,000
0
19,000Form 4
KEELER MITCH
former off., dir., 10% owner
2004-03-12 13:52:5315,000
0
15,000Form 13G
Shepard H. Michael
VP, Chief Scientific Officer
2013-09-11 18:12:0713,198
0
13,198Form 4
Kennard Don A
Vice President, Regulatory Aff
2007-05-23 16:16:590
0
0Form 4